Project Grant R01AG087295
Award Date
5/1/24
Completion Date
4/30/29
Dollars Obligated
$2.1M
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Boulder, CO 80309, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $633,376 to Colorado State University to conduct research aimed at understanding how age-related declines in endosome formation contribute to the development of Alzheimer's disease (AD) and other protein-based neurodegenerative disorders. The key objectives are to: 1) Determine how increasing endosome formation can decrease pathological tau protein levels in neurons, and 2) Evaluate the impact...
This $326,797 federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) aims to use proteomic analyses to identify proteins and protein networks associated with mild cognitive impairment in individuals with type 2 diabetes. The project's primary goal is to illuminate the underlying molecular mechanisms driving cognitive impairment in this population, with the potential to identify biomarkers for risk stratification and protein targets for therapeutic...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) in the amount of $652,575 provides funding to New York University School of Medicine to conduct research on the disruption of endosomal microautophagy (EMI) by pathological tau protein in Alzheimer's disease (AD). The key objectives are to 1) elucidate the role of pathological tau in destabilizing the EMI pathway, 2) identify which EMI components are most vulnerable to tau pathology, and 3)...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), will investigate the synergistic relationship between the tau and TDP-43 proteins in the pathogenesis of Alzheimer's disease (AD). The $757,027 award, effective from January 1, 2025 to December 31, 2029, will utilize a C. elegans model to interrogate the mechanistic pathways underlying the interaction between tau and TDP-43 proteinopathies. The project aims to identify...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,380,018 to the Regents of the University of Michigan to conduct research on the impact of type 2 diabetes and prediabetes on cognitive decline and Alzheimer's disease risk over the life course. The research team will quantify how cumulative hyperglycemia and diabetes management affect cognitive trajectories and Alzheimer's disease risk, and identify potential mechanisms linking...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Arizona State University provides $431,750 in funding to conduct research on the role of tau protein proteolysis in Alzheimer's disease. The key objectives are to: 1) test and rank the ability of tau protein peptide fragments generated by proteolysis to induce the aggregation of full-length tau protein, and 2) characterize the intracellular signaling activity of these tau peptides. Using...
The National Institute on Aging (NIA) awarded a $7,249,563 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of California, San Francisco (UCSF). This 3-year award, starting on Aug 1, 2023, will support research to characterize the structural properties and variability of tau protein aggregation in different brain cell types and at different disease stages of Alzheimer's and related dementias (ADRD).
The project aims to develop new...
The National Institute on Aging (NIA), through the Aging Research Federal Grant Program (CFDA 93.866), awarded a $1,562,788 Project Grant (R01AG085469) to the University of Florida to comprehensively profile the blood (serum) and brain N-glycome in relation to Alzheimer's disease (AD). The project will leverage the large collection of biospecimens and data from two community-based prospective cohorts to understand the mechanisms through which aberrant N-glycosylation affects AD and identify...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $4,151,128 to The Winifred Masterson Burke Medical Research Institute, Inc. to investigate the role of neuronal hyperexcitability and proteostasis (protein homeostasis) in the pathogenesis of Alzheimer's disease. The 5-year project, which began on September 1, 2024, aims to elucidate how modifications in brain activity, particularly in the locus coeruleus and hippocampus, can lead to...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $795,436 to Rutgers, The State University of New Jersey to study the role of the glycoproteome in Alzheimer's disease and related dementias (AD/ADRD). The key products and services delivered under this award include:
Using a novel glycoproteome-wide analysis method to identify glycopeptiforms (sugar-modified proteins) related to AD/ADRD pathologies and clinical traits, including...